Related Experiment Video
Updated: Mar 26, 2026
05:41
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
3.6K
[Enteric microbiocenotic modifiers and ways of enhancing their efficacy]
E V Lipova1, A B Yakovlev1, A A Aivazian1
1Central State Medical Academy, Department for Presidential Affairs of the Russian Federation, Moscow, Russia.
Terapevticheskii Arkhiv
|January 30, 2016
Summary
Restoring gut microbiota is crucial, especially after antibiotics. Combined therapies, like Bion-3 with probiotics, vitamins, and minerals, show effectiveness in enhancing gut health and acting as an adaptogen.
Area of Science:
- Microbiology
- Gastroenterology
- Pharmacology
Context:
- Efficient recovery of the enteric microbiocenosis is a significant challenge.
- Antibiotic treatment severely disrupts gut microbiota.
- Restoring gut flora is essential for overall health.
Purpose:
- To highlight the importance of enteric microbiocenosis recovery.
- To identify effective therapeutic strategies for gut microbiota restoration.
- To introduce Bion-3 as a beneficial combined modifier.
Summary:
- Combined modifiers of enteric microbiocenosis are more effective than other symbiotic drugs.
- Bion-3 contains beneficial symbionts, a vitamin/mineral complex, and acts as an adaptogen.
- This formulation aids in the efficient recovery of gut microbiota.
Impact:
- Provides insights into managing gut dysbiosis post-antibiotics.
- Suggests Bion-3 as a promising therapeutic option.
- Emphasizes the role of multi-component drugs in restoring gut health.
More Related Videos
Related Concept Videos
01:22Probiotics
68
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
68
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
01:18Functions of the Gut Microbiota
24
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
24
01:22Introduction to the Human Microbiota
44
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
44
01:27Microbiota of the Stomach and Small Intestine
17
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
17
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
308
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
308